<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Southern blot analysis was conducted in 15 patients by using a 1.2 Kb Hind III/Bgl II fragment from the 3' end of the bcr region and a 2.0 Kb Bgl II/Hind III fragment from the 5' end of the bcr as probes </plain></SENT>
<SENT sid="1" pm="."><plain>Of the 15 patients in our group, 11 with <z:hpo ids='HP_0011010'>chronic</z:hpo>, myelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), 3 with Ph-negative <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ALL), one with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Bcr rearrangements were detected in 9 patients with <z:mp ids='MP_0005481'>CML</z:mp> and were negative in the rest of the patients </plain></SENT>
<SENT sid="3" pm="."><plain>The results showed that the identification of bcr rearrangement was very important in the diagnosis of Ph-positive <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
</text></document>